Innate Pharma (IDDA) Balance Sheet

Innate Pharma's total assets for Q2 2026 were €34.71M, a decrease of -44.63% from the previous quarter. DE:IDDA total liabilities were €75.20M for the fiscal quarter, a -10.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.